Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Editor's Picks
12/5/2023
China Biotech: Investors Fear a Negative Reaction from the US (FT)
11/24/2023
China Biopharma: Charting a Path to Value Creation (McKinsey)
11/24/2023
China Gearing Up to Take on Pharmaceutical Giants, Drive Biotech Boom ...
11/23/2023
PharmaDJ's China Biopharma Tracker – October 2023 (PharmaDJ)
11/22/2023
Mixed Q3 For China's Innovative Firms Amid Anti-Graft Campaign (SCRIP ...
11/20/2023
Reflections from the 10th BioCentury-BayHelix China Summit, and Other ...
11/16/2023
Riding The Tide, Realize the Future: The BD Paths For Chinese Biotech ...
11/16/2023
Chinese Patent Office Hands Down Key Ruling on Pharma Patent Requireme...
11/15/2023
China CEO Interview: Gracell Aims To Enter US CAR-T Sector Through Par...
11/14/2023
NMPA: Quick Review of 2022 Drug Review Annual Report
11/10/2023
China's Strength Is Innovation on Innovation, Western Partners Are Lin...
11/8/2023
The Growing Pains of Chinese Biotech (In Vivo Citeline)
11/6/2023
Q3 Sees Fewer Pharma Financing Deals But Upticks in Ophthalmology and ...
10/31/2023
Coherus Rejects 'Heavily Discounted' Pricing on Loqtorzi, the First Ch...
10/29/2023
2023 Outlook for China's NRDL (Simon Kucher)
10/26/2023
Patent Linkage In China: What Do The First Decisions Tell Us About The...
10/24/2023
Infographic: Rare diseases in China (Research Partnership)
10/17/2023
China: The New Frontier for Western CDMOs? (Contract Pharma)
10/15/2023
The Rising Importance of Patient Advocacy Innovations in Asia (PharmEx...
10/15/2023
Pfizer CEO Albert Bourla Wants To Tap 'Chinese Science' As The Drug Co...
10/12/2023
China's Vast Opportunities In Health Care Attract Global Telemedicine ...
10/10/2023
China Market Opportunities for International Pharmas (Lek)
10/9/2023
MNCs Wary of Pouring Big Investments in China While Actively Seeking L...
9/28/2023
Overview of Recent Anti-Corruption Enforcement Actions in the Pharmace...
9/26/2023
AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happe...
9/26/2023
Patent Linkage In China: What The First Decisions Reveal About The Dir...
9/24/2023
Improving Access to Medicines and Beyond: the National Volume-based Pr...
9/24/2023
Strategies for Asian Business Navigating a New Era (McKinsey)
9/20/2023
Chinese Drugmakers Hit a Fundraising and Licensing Slump in August (Ph...
9/19/2023
Researchers Must Navigate Thorny New Data Security Laws (UWN)
Page:
5
/
7
Total number of articles:
181
:
[First]
[<<]
[3]
[4]
[5]
[6]
[7]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit